Group items tagged

Why data resource profiles (DRPs)? We can't do epidemiology without data. Data are cen- tral to epidemiology's three main challenges: to describe health states in populations, make inferences about their causes and to apply that knowledge to improve health. The more high quality data we have to support these three tasks, the better.10,11 The challenge of providing health data coverage on a global scale is immense. Termed a 'scandal of invisi- bility', in the world's least developed countries more than two-thirds of all births and deaths go unregis- tered.12 Meanwhile, in advanced industrialised na- tions publicly funded data collection systems are under threat, particularly at a time of state retrench- ment.13 In the UK and Canada the long-form census was cancelled. Canada, too, cancelled some of its premier longitudinal studies of children and youth, leaving the country with little signal about the state of human capability development of its future gener- ations. Removing parts of the publicly funded health information infrastructure is easy, but rebuilding sur- veillance will require orders of magnitude more vision, dedication and money.

"The death rate from cervical cancer in the United States is considerably higher than previously estimated and the disparity in death rates between black women and white women is significantly wider, according to a study published Monday in the journal Cancer. The rate at which black American women are dying from the disease is comparable to that of women in many poor developing nations, researchers reported. What makes the findings especially disturbing, said experts not involved in the research, is that when screening guidelines and follow-up monitoring are pursued, cervical cancer is largely preventable."

"Tests for hereditary predispositions to breast and ovarian cancer have figured among the first medical applications of the new knowledge gleaned from the Human Genome Project. These applications have set off heated debates on general issues such as intellectual property rights. The genetic diagnosis of breast cancer risks, and the management of women "at risk" has nevertheless developed following highly localized paths. There are major differences in the organization of testing, uses of genetic tests, and the follow up of patients. This article studies testing practices and ways of managing breast cancer risk in France and compares them with those in the United States and United Kingdom. It shows how the complex interaction between global and local factors shapes the multiple meanings assumed by the phrase cancer risk."

A population approach to obesity reduction

Breast cancer incidence rates increased in 80s and 90s then decreased. Death rates haev decreased since 1989.